Northern Trust Corp Compugen LTD Transaction History
Northern Trust Corp
- $709 Billion
- Q2 2025
A detailed history of Northern Trust Corp transactions in Compugen LTD stock. As of the latest transaction made, Northern Trust Corp holds 889,716 shares of CGEN stock, worth $1.31 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
889,716
Previous 881,235
0.96%
Holding current value
$1.31 Million
Previous $1.29 Million
23.09%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding CGEN
# of Institutions
79Shares Held
16.2MCall Options Held
28.7KPut Options Held
48.3K-
Silverarc Capital Management, LLC2.9MShares$4.26 Million1.03% of portfolio
-
Morgan Stanley New York, NY1.39MShares$2.04 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.33MShares$1.95 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.07MShares$1.58 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C31.02MShares$1.5 Million0.0% of portfolio
About COMPUGEN LTD
- Ticker CGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,600
- Market Cap $127M
- Description
- Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...